ask="0.9150"
ask_size="500"
average_daily_volume="1159020"
bid="0.8312"
bid_size="500"
book_value="0.6060"
change="-0.0449"
change_from_200_day_moving_average="-1.9858"
change_from_50_day_moving_average="-0.0797"
change_from_52_week_high="-4.0448"
change_From_52_week_low="0.3851"
change_in_percent="-4.8280%"
close="0.8851"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.2370"
ebitda="-8.78M"
eps_estimate_current_year="-1.1200"
eps_estimate_next_quarter="-0.2500"
eps_estimate_next_year="0.1900"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.9800"
high_52_weeks="4.9299"
last_trade_date="1/11/2017"
last_trade_price="0.8851"
last_trade_size="600"
last_trade_time="3:59pm"
low="0.8850"
low_52_weeks="0.5000"
market_capitalization="6.32M"
moving_average_200_day="2.8709"
moving_average_50_day="0.9648"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.3300"
open="0.9700"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-69.1695%"
percent_change_from_50_day_moving_average="-8.2654%"
percent_change_from_52_week_high="-82.0463%"
percent_change_from_52_week_low="+77.0200%"
previous_close="0.9300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="4.6584"
price_per_book="1.5347"
price_per_sales="2.5979"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.2200"
stock_exchange="NCM"
symbol="OPXA"
volume="470986"
weeks_range_52="0.5000 - 4.9299"
